Literature DB >> 31041459

Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy.

Shakuntla Gondalia1, Lisa Parkinson2, Con Stough2, Andrew Scholey2.   

Abstract

There is increasing evidence that connections formed between microbiome, the gut, and the brain play a role in health and well-being. Non-pharmaceutical targets for management of mood disorders, such as bipolar disorder, are relatively under-researched. At the same time, it is clear that there is an intimate connection between psychiatry and gastrointestinal health. Here, we have discussed various comorbid conditions associated with bipolar disorders such as inflammation, irritable bowel disease and antibiotic induced mania with importance to demonstrate possible involvement of the gut microbiota. Gut microbiota-targeted preclinical and clinical interventions have demonstrated enhancement in various psychological conditions. Further in this review, we explore links between bipolar disorder, inflammation and gut microbiome with a focus on dietary, pro- and pre-biotic interventions as potential adjuvant therapies for use in the management of mood disorders such as bipolar disorder.

Entities:  

Keywords:  Adjuvant therapy; Antibiomania; Antibiotic; Bipolar disorder; Gut microbiome; Immunity; Inflammation; Probiotics

Mesh:

Substances:

Year:  2019        PMID: 31041459     DOI: 10.1007/s00213-019-05248-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  108 in total

1.  γ-Aminobutyric acid production by culturable bacteria from the human intestine.

Authors:  E Barrett; R P Ross; P W O'Toole; G F Fitzgerald; C Stanton
Journal:  J Appl Microbiol       Date:  2012-06-15       Impact factor: 3.772

2.  Serum folate, vitamin B-12, and homocysteine and their association with depressive symptoms among U.S. adults.

Authors:  May A Beydoun; Monal R Shroff; Hind A Beydoun; Alan B Zonderman
Journal:  Psychosom Med       Date:  2010-09-14       Impact factor: 4.312

Review 3.  Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.

Authors:  M Berk; F Kapczinski; A C Andreazza; O M Dean; F Giorlando; M Maes; M Yücel; C S Gama; S Dodd; B Dean; P V S Magalhães; P Amminger; P McGorry; G S Malhi
Journal:  Neurosci Biobehav Rev       Date:  2010-10-08       Impact factor: 8.989

4.  Impact of consuming a milk drink containing a probiotic on mood and cognition.

Authors:  D Benton; C Williams; A Brown
Journal:  Eur J Clin Nutr       Date:  2006-12-06       Impact factor: 4.016

5.  A preliminary report of increased plasma levels of IL-33 in bipolar disorder: further evidence of pro-inflammatory status.

Authors:  Izabela Guimaraes Barbosa; Isabela Boechat Morato; Aline Silva de Miranda; Moisés Evandro Bauer; Jair C Soares; Antônio Lucio Teixeira
Journal:  J Affect Disord       Date:  2014-01-11       Impact factor: 4.839

Review 6.  Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety.

Authors:  Esther Asan; Maria Steinke; Klaus-Peter Lesch
Journal:  Histochem Cell Biol       Date:  2013-03-15       Impact factor: 4.304

7.  The effects of argon laser on in vitro aggregation of platelets in platelet rich plasma and whole blood.

Authors:  P T Doerger; H I Glueck; M McGill
Journal:  Thromb Res       Date:  1988-06-01       Impact factor: 3.944

Review 8.  Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies.

Authors:  M Asberg
Journal:  Ann N Y Acad Sci       Date:  1997-12-29       Impact factor: 5.691

9.  Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study.

Authors:  Michael E Benros; Berit L Waltoft; Merete Nordentoft; Søren D Ostergaard; William W Eaton; Jesper Krogh; Preben B Mortensen
Journal:  JAMA Psychiatry       Date:  2013-08       Impact factor: 21.596

10.  Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial.

Authors:  Ghodarz Akkasheh; Zahra Kashani-Poor; Maryam Tajabadi-Ebrahimi; Parvaneh Jafari; Hossein Akbari; Mohsen Taghizadeh; Mohammad Reza Memarzadeh; Zatollah Asemi; Ahmad Esmaillzadeh
Journal:  Nutrition       Date:  2015-09-28       Impact factor: 4.008

View more
  8 in total

1.  Gut microbiota: a missing link in psychiatry.

Authors:  Timothy G Dinan; John F Cryan
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

2.  Longitudinal gut microbiome changes in alcohol use disorder are influenced by abstinence and drinking quantity.

Authors:  Nancy J Ames; Jennifer J Barb; Kornel Schuebel; Sarah Mudra; Brianna K Meeks; Ralph Thadeus S Tuason; Alyssa T Brooks; Narjis Kazmi; Shanna Yang; Kelly Ratteree; Nancy Diazgranados; Michael Krumlauf; Gwenyth R Wallen; David Goldman
Journal:  Gut Microbes       Date:  2020-11-01

Review 3.  Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders.

Authors:  Laura Mitrea; Silvia-Amalia Nemeş; Katalin Szabo; Bernadette-Emőke Teleky; Dan-Cristian Vodnar
Journal:  Front Med (Lausanne)       Date:  2022-03-31

4.  Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy.

Authors:  Seyed Aria Nejadghaderi; Ehsan Nazemalhosseini-Mojarad; Hamid Asadzadeh Aghdaei
Journal:  Med Hypotheses       Date:  2020-12-31       Impact factor: 4.411

5.  Gut permeability and its clinical relevance in schizophrenia.

Authors:  Ikki Ishida; Jun Ogura; Emiko Aizawa; Miho Ota; Shinsuke Hidese; Yukihito Yomogida; Junko Matsuo; Sumiko Yoshida; Hiroshi Kunugi
Journal:  Neuropsychopharmacol Rep       Date:  2022-01-25

6.  Gut Microbiota Associated With Effectiveness And Responsiveness to Mindfulness-Based Cognitive Therapy in Improving Trait Anxiety.

Authors:  Zonghua Wang; Shuang Liu; Xiaoxiao Xu; Yufeng Xiao; Min Yang; Xiaoyan Zhao; Cancan Jin; Feng Hu; Shiming Yang; Bo Tang; Caiping Song; Tao Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-02-24       Impact factor: 5.293

7.  The safety and efficacy of fecal microbiota transplantation in a population with bipolar disorder during depressive episodes: study protocol for a pilot randomized controlled trial.

Authors:  Noah C A Cooke; Asem Bala; Johane P Allard; Susy Hota; Susan Poutanen; Valerie H Taylor
Journal:  Pilot Feasibility Stud       Date:  2021-07-14

Review 8.  Alterations in the Nervous System and Gut Microbiota after β-Hemolytic Streptococcus Group A Infection-Characteristics and Diagnostic Criteria of PANDAS Recognition.

Authors:  Jacek Baj; Elżbieta Sitarz; Alicja Forma; Katarzyna Wróblewska; Hanna Karakuła-Juchnowicz
Journal:  Int J Mol Sci       Date:  2020-02-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.